Sun Pharma gets reprieve as FDA clears key Halol plant

Investors in Sun Pharma can breathe a sigh of relief after the company said Tuesday the Food and Drug Administration had cleared its key Halol manufacturing plant, resolving a long-standing regulatory headache for the drugmaker.